Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bedaquiline plus delamanid for XDR tuberculosis.
Lachâtre M, Rioux C, Le Dû D, Fréchet-Jachym M, Veziris N, Bouvet E, Yazdanpanah Y. Lachâtre M, et al. Among authors: veziris n. Lancet Infect Dis. 2016 Mar;16(3):294. doi: 10.1016/S1473-3099(16)00047-5. Lancet Infect Dis. 2016. PMID: 26973310 No abstract available.
Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
Amarsy R, Trystram D, Cambau E, Monteil C, Fournier S, Oliary J, Junot H, Sabatier P, Porcher R, Robert J, Jarlier V; “la Collégiale de Bactériologie–Virologie–Hygiène de l'Assistance Publique – Hôpitaux de Paris”. Amarsy R, et al. Int J Infect Dis. 2022 Jan;114:90-96. doi: 10.1016/j.ijid.2021.10.034. Epub 2021 Oct 22. Int J Infect Dis. 2022. PMID: 34688945 Free PMC article.
Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones.
Matrat S, Veziris N, Mayer C, Jarlier V, Truffot-Pernot C, Camuset J, Bouvet E, Cambau E, Aubry A. Matrat S, et al. Among authors: veziris n. Antimicrob Agents Chemother. 2006 Dec;50(12):4170-3. doi: 10.1128/AAC.00944-06. Epub 2006 Oct 2. Antimicrob Agents Chemother. 2006. PMID: 17015625 Free PMC article.
[Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis].
Bergot E, Abiteboul D, Andréjak C, Antoun F, Barras E, Blanc FX, Bourgarit A, Charlois-Ou C, Delacourt C, Dirou S, Gerin M, Guerin S, Haustraete É, Henry B, Lucet JC, Maitre T, Morin J, Le Palud P, Pommelet V, Rivoisy C, Robert J, Veziris N, Herrmann JL. Bergot E, et al. Among authors: veziris n. Rev Mal Respir. 2018 Oct;35(8):852-858. doi: 10.1016/j.rmr.2018.08.007. Epub 2018 Sep 14. Rev Mal Respir. 2018. PMID: 30224215 French. No abstract available.
Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB).
De Castro N, Mechaï F, Bachelet D, Canestri A, Joly V, Vandenhende M, Boutoille D, Kerjouan M, Veziris N, Molina JM, Grall N, Tattevin P, Laouénan C, Yazdanpanah Y; FAST TB Study Group. De Castro N, et al. Among authors: veziris n. Open Forum Infect Dis. 2022 Jul 25;9(8):ofac353. doi: 10.1093/ofid/ofac353. eCollection 2022 Aug. Open Forum Infect Dis. 2022. PMID: 35949399 Free PMC article.
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.
Lange C, Duarte R, Fréchet-Jachym M, Guenther G, Guglielmetti L, Olaru ID, Oliveira O, Rumetshofer R, Veziris N, van Leth F; European MDR-TB database collaboration *. Lange C, et al. Among authors: veziris n. Am J Respir Crit Care Med. 2016 Oct 15;194(8):1029-1031. doi: 10.1164/rccm.201606-1097LE. Am J Respir Crit Care Med. 2016. PMID: 27685538 No abstract available.
168 results